Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | MAPT | P10636 | 3/20 | 0.72 |
| ▸ | HTT | P42858 | 3/20 | 0.72 |
| ▸ | RAB9A | P51151 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.72 |
| ▸ | CFTR | P13569 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19032775 | 0.88 | CFTR (0.72) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL17653408 | 0.87 | MEN1 (0.74) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL19452294 | 0.84 | MEN1 (1.00) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL24363056 | 0.77 | CFTR (0.72) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL27428371 | 0.76 | CFTR (0.59) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL19046548 | 0.76 | CFTR (0.85) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL19046547 | 0.76 | CFTR (0.69) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL16883060 | 0.75 | MAPK1 (0.54) | MEN1KMT2AMAPTRAB9AMAPK1 | |
| SCHEMBL1913790 | 0.75 | MAPT (0.78) | MEN1KMT2AMAPTHTTRAB9A | |
| SCHEMBL980645 | 0.75 | MAPK1 (0.57) | MEN1KMT2AMAPTHTTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170291879-A1 | Cancer Cell Growth Inhibitor, Anticancer Agent, and Method for Screening Same, as well as Novel Compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2017-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170291879-A1 | Cancer Cell Growth Inhibitor, Anticancer Agent, and Method for Screening Same, as well as Novel Compound | EGFR, MKI67, ERBB2 | MEN1 1484/4885KMT2A 1709/4885MAPT 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.